European Association of Nuclear Medicine

Name

European Association of Nuclear Medicine

Legal name

European Association of Nuclear Medicine

Website

https://eanm.org

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Professional Medical Association Services

NAICS

Other Scientific and Technical Consulting Services (541690), Other Scientific and Technical Consulting Services (54169), Management, Scientific, and Technical Consulting Services (5416)

SIC

Services-Membership Organizations (8600), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Nuclear Materials Testing, Assay & Characterization Services (NDA/NDE, radiochemistry, materials analysis) (EUAKAIAL)

akta.pro secondary industries

Quality Assurance Programs & Nuclear Quality Standards (ASME NQA-1, ISO 9001, IAEA) (EUAKAEAC), Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

Keywords

• Nuclear medicine education
• Medical congress services
• Professional medical association
• Radiology certification programs
• Clinical decision support

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Membership Fees: Annual membership fees from nuclear medicine professionals, with various membership tiers including regular, junior, associate, and nurse/technologist categories
2. Congress Registration Fees: Revenue from Annual Congress and Focus Meetings registration, with tiered pricing for members, non-members, students, and accompanying persons
3. Educational Programs: Revenue from ESMIT courses, certifications including Nuclear Cardiology Certification and Radiopharmacy Certification, and FEBNM examination fees
4. Publications and Journals: Revenue from EANM journals including The EANM Journal and EANM Innovation, both open-access online publications
5. Corporate Membership and Sponsorship: Support from pharmaceutical and medical imaging companies as corporate members

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels9 records

Core offering

The European Association of Nuclear Medicine (EANM) is a non-profit professional medical association that delivers scientific congresses, continuing education, peer-reviewed publications, board certifications, and clinical decision support resources for nuclear medicine professionals across Europe. It operates the annual EANM Congress, two open-access journals (The EANM Journal and EANM Innovation), the ESMIT educational school, the FEBNM fellowship examination, the EARL accreditation program, and the Clinical Decision Support Tool for procedure selection.

Product overview

The European Association of Nuclear Medicine (EANM) is a professional medical organization, not a software product company. Its offerings consist of educational programs, scientific publications, congresses, certifications, and clinical decision support tools. The core portfolio includes the annual EANM Congress, two open-access journals (The EANM Journal and EANM Innovation), ESMIT (European School of Multimodality Imaging and Therapy) with its AD-LEARN and Radioligand Therapy Academy modules, the Clinical Decision Support tool and European Nuclear Medicine Guide for clinical practice, EANM Podcast for media engagement, and various awards including the Young Scientist Network Award. EANM also operates the EARL research lab, the INSPIRE initiative for future workforce, and provides FEBNM certification through the UEMS/EBNM framework. The myEANM portal serves members while congress registration is handled through the m-anage.com platform.

Differentiator

Problem solved

Functional benefit

Brands

• ESMIT (European School of Multimodality Imaging and Therapy): European School of Multimodality Imaging and Therapy providing education and training programs in nuclear medicine
• EARL
• INSPIRE by EANM
• RLT Academy

Products and services

• EANM Annual Congress EANM's flagship annual scientific congress featuring scientific sessions, poster presentations, industry exhibitions, and awards for nuclear medicine professionals from across Europe and beyond. EANM'26 is scheduled for October 17-21, 2026 in Vienna, Austria.
• The EANM Journal Open-access, online-only journal publishing scientific research in nuclear medicine. One of two EANM-owned journals launched in 2025.
• EANM Innovation Open-access, online-only journal focused on innovation in nuclear medicine. One of two EANM-owned journals launched in 2025.
• European School of Multimodality Imaging and Therapy (ESMIT) Educational platform providing in-person and online courses, certifications (Nuclear Cardiology Certification, Radiopharmacy Certification), and learning opportunities in multimodality imaging and therapy for nuclear medicine professionals.
• AD-LEARN Online e-learning platform for nuclear medicine education and professional development, operated within the ESMIT framework.
• Radioligand Therapy (RLT) Academy Dedicated academy for training and education in radioligand therapy, delivered within the ESMIT educational framework for nuclear medicine professionals.
• Clinical Decision Support (CDS) Tool Digital platform guiding clinicians in selecting appropriate nuclear medicine procedures to enhance patient care. Redesigned and fully updated version launched in June 2024.
• European Nuclear Medicine Guide Comprehensive reference guide for nuclear medicine practices across Europe, with the 2026 edition released in January 2026.
• EANM Podcast EANM's first podcast programme covering the latest news in nuclear medicine and allied sciences, complementing EANM journals with author and researcher insights. First episode expected in fall 2026, hosted by Mariana Andrade.
• EARL (EANM Research Ltd) EANM's accreditation and quality assurance program for nuclear medicine facilities, including PET/CT accreditation, ensuring standards across European centers.
• EANM Focus Meetings Specialized smaller scientific meetings complementing the annual congress, covering specific topics in nuclear medicine (e.g., Focus Meeting 7).
• International Conference on Nuclear Cardiology (ICNC) Joint conference on nuclear cardiology held in collaboration with partner societies, with ICNC2026 edition scheduled.
• Young Investigators Meeting Annual scientific meeting designed specifically for young researchers and professionals in nuclear medicine.
• FEBNM (Fellowship of the European Board of Nuclear Medicine) European Board certification proving knowledge and competence in Nuclear Medicine, administered through UEMS/EBNM with MCQ and Oral examination components.
• myEANM Member Portal Member portal providing EANM members access to their membership area, congress registration, abstract submission, and personalized services.
• INSPIRE by EANM Initiative supporting young professionals and future workforce development in nuclear medicine, including the Women's Empowerment program.

Quantifiable outcome

• About 91% survival rate of antiprotons during CERN road transport test - research presented at EANM Congress
• +2 more outcomes

Named customers10 records

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

14 partnerships are on record, tiered core and major.

• EORTC (European Organisation for Research and Treatment of Cancer)coreStrategic or Co-development Partner · 8 October 2025EORTC advances radioligand therapy through collaboration with EANM and a dedicated Radioligand Task Force, as highlighted at the EANM Congress in Barcelona. Three clinical trials profiled: LUMEN-1, RENALUT, and PEACE III.
• NovartismajorGTM or Marketing Partner · 8 October 2025Novartis supports EORTC-EANM radioligand trials including PEACE III trial evaluating radium-223 combined with enzalutamide for prostate cancer patients with bone metastases.
• Bayer HealthCare Pharmaceuticals Inc.majorGTM or Marketing Partner · 8 October 2025Bayer supports EORTC-EANM radioligand therapy clinical trials through their pharmaceutical products in radioligand therapy.
• ICPO FoundationcoreStrategic or Co-development Partner · 20 June 2025ICPO Foundation co-founded the RLT Angels Association alongside EANM, GE HealthCare, Novartis, and RayzeBio (Bristol Myers Squibb company) to improve access to radioligand imaging and therapies for up to one million patients globally. Initiative aims to establish 1,000 RLT Centers worldwide with open-source best practices, accreditation standards, and educational tools.
• GE HealthCarecoreStrategic or Co-development Partner · 20 June 2025GE HealthCare partnered with EANM to co-found the RLT Angels Association, aiming to grow access to radiotheranostics to one million patients globally through establishing 1,000 RLT Centers worldwide.
• NovartiscoreStrategic or Co-development Partner · 20 June 2025Novartis partnered with EANM to co-found the RLT Angels Association for radioligand therapy access expansion, with approximately 225 ongoing clinical trials across more than 15 cancer indications.
• RayzeBio (Bristol Myers Squibb)coreStrategic or Co-development Partner · 20 June 2025RayzeBio, a Bristol Myers Squibb company, partnered with EANM to co-found the RLT Angels Association for improving radioligand therapy access globally.
• 40 European National SocietiescoreStrategic or Co-development PartnerEANM collaborates with 40 European nuclear medicine national societies to enhance patient care through the transformative potential of nuclear medicine.
• 20 Non-European Affiliated SocietiesmajorStrategic or Co-development PartnerEANM collaborates with 20 non-European affiliated societies for international knowledge sharing and professional development in nuclear medicine.
• EU InstitutionscoreStrategic or Co-development PartnerEANM engages with EU institutions on policy matters affecting nuclear medicine, including the Biotech Act revision, MDR/IVDR, and European Health Data Space.
• European Society of Radiology (ESR)majorStrategic or Co-development PartnerEANM collaborates with ESR on cardiovascular imaging initiatives including the 'Imaging Saves Lives' event co-organized at the European Parliament.
• SNMMI (Society of Nuclear Medicine and Molecular Imaging)coreStrategic or Co-development PartnerEANM and SNMMI, along with ARTnet, launched unified PET accreditation to improve clinical trials and patient care. Also collaborate on technologist programs.
• ARTnetmajorStrategic or Co-development PartnerEANM, SNMMI, and ARTnet launched unified PET accreditation initiative to standardize PET imaging and improve clinical trials and patient care.
• Corporate Members (50+ companies)majorGTM or Marketing PartnerEANM's corporate membership includes 50+ pharmaceutical and medical device companies including GE HealthCare, Siemens Healthineers, Novartis, Bayer AG, Telix Pharmaceuticals, Curium, and others. Corporate members support congresses and receive exhibition/sponsorship opportunities.

Scale indicators8 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• World Federation of Nuclear Medicine and Biology (WFNMB): WFNMB is the global nuclear medicine professional body, making it a direct peer in mission and scope. It complements EANM's European regional focus with worldwide membership and congress activities.
• International Society for Magnetic Resonance in Medicine (ISMRM): ISMRM is a global peer professional society for MR medicine with comparable congress, journal, and educational models. It competes with EANM for radiology professional mindshare in hybrid imaging (PET/MR).
• Society of Nuclear Medicine and Molecular Imaging (SNMMI): SNMMI is the US counterpart professional association for nuclear medicine, directly comparable in mission, offering journals (JNM), annual meetings, and technologist certifications. SNMMI and EANM jointly launched unified PET accreditation and collaborate on technologist programs.
• European Society of Radiology (ESR): ESR is a peer European medical professional association in radiology that collaborates with EANM on cardiovascular imaging initiatives including the 'Imaging Saves Lives' event at the European Parliament. Both operate congresses, journals, and educational programs at similar scale.
• European Society for Radiotherapy and Oncology (ESTRO): ESTRO is a European medical professional association in radiation oncology with comparable congress, journal (Radiotherapy and Oncology), and educational programs. It overlaps with EANM at the radiotherapy-radiopharmaceutical intersection.

Emerging players

• ICPO Foundation: ICPO Foundation is a direct partner that co-founded the RLT Angels Association with EANM. It is an emerging global player in radioligand therapy access and education with overlapping mission and a similar non-profit orientation.

Broad incumbents

• European Society of Cardiology (ESC): ESC is a large European medical association with similar congress, journal, and certification programs. It collaborates with EANM through the International Conference on Nuclear Cardiology (ICNC) and overlaps in cardiac imaging.
• European Society for Medical Oncology (ESMO): ESMO is a large European medical professional association with comparable governance, congress, and journal model. ESMO's broader oncology focus overlaps with EANM's radioligand therapy work in cancer and shares many of the same pharma sponsors.
• American Society of Clinical Oncology (ASCO): ASCO is a major US-based oncology professional society with similar congress, journal, and membership economics. It serves as the benchmark for oncology-related professional societies and increasingly intersects with nuclear medicine through theranostics.

Regional players

• European Association of Urology (EAU): EAU is a European specialty medical association comparable in scale and governance model, with annual congresses, journals (European Urology), and educational offerings. EAU overlaps with EANM through prostate cancer imaging and radioligand therapy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/officialEANM
• YouTubeyoutube.com/officialEANM
• Facebookfacebook.com/officialEANM
• LinkedInlinkedin.com/company/officialeanm
• Instagraminstagram.com/eanm_nucmed

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European Association of Nuclear Medicine